Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer

Clinical trial NCT05783323 · RECRUITING

Trial details

NCT number: NCT05783323
Sponsor: Children's Hospital of Philadelphia
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Differentiated Thyroid Cancer Pediatric Cancer Cancer Cancer, Thyroid

Start date: 2024-02-14
Primary completion: 2026-10-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.